TriSalus Life Sciences (TLSIW) Gross Profit (2022 - 2026)

TriSalus Life Sciences has reported Gross Profit for 5 years, with the latest figure at $7.7 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit changed 0.04% year-over-year to $7.7 million; the trailing twelve-month figure through Mar 2026 stood at $38.2 million (up 38.78% YoY), and the FY2025 full-year result was $38.2 million, up 50.77% from the prior year.
• Gross Profit for Q1 2026 stood at $7.7 million, down from $11.4 million in the prior quarter.
• The five-year high for Gross Profit was $11.4 million in Q4 2025, with the low at $2.3 million in Q1 2023.
• Historically, Gross Profit has averaged $6.2 million across 5 years, with a median of $6.3 million in 2024.
• Annual changes were most pronounced in 2024 — Gross Profit soared 136.26% — and 2026, when it decreased 0.04%.
• TriSalus Life Sciences' Gross Profit stood at $2.4 million in 2022, then jumped by 113.24% to $5.1 million in 2023, then jumped by 37.09% to $7.0 million in 2024, then soared by 62.43% to $11.4 million in 2025, then plunged by 32.98% to $7.7 million in 2026.
• The last three Gross Profit figures came in at $7.7 million (Q1 2026), $11.4 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.